The United kingdom Startup Ecosystem

Overview

The United Kingdom has a thriving startup ecosystem, particularly centered in London, which is a major global tech hub. As of 2023, the UK is home to approximately 30,000 startups. The UK government supports innovation through initiatives like the Enterprise Investment Scheme (EIS) and Seed Enterprise Investment Scheme (SEIS), which provide tax incentives for investors. In 2022, UK startups raised over £30 billion in venture capital.

Size of the Market

The UK startup ecosystem is substantial, with around 30,000 startups as of 2023. In 2022, UK startups raised over £30 billion in venture capital, indicating strong investor confidence and a robust market for entrepreneurial ventures. This financial support is critical for the growth and sustainability of new businesses.

Key Strengths

Key strengths of the UK market include a strong financial sector, world-class universities, and a diverse talent pool. The UK is known for its strengths in fintech, healthtech, and creative industries. London is a hotspot for fintech innovation, housing numerous unicorns such as Revolut and TransferWise.

Major Hubs

London remains the central hub for startups in the UK, particularly excelling in fintech and creative industries. The city is home to numerous high-growth startups and unicorns. Its position as a global financial center attracts significant venture capital and talent.

Emerging Hubs

Other cities like Manchester, Edinburgh, and Cambridge are making significant contributions to the startup landscape. Manchester is known for its tech and media industries, Edinburgh excels in fintech and AI, while Cambridge is renowned for life sciences and advanced manufacturing.

Support Systems

The UK startup ecosystem benefits from a robust support network of accelerators, incubators, and co-working spaces. Programs like Tech Nation and Innovate UK have been pivotal in fostering a supportive environment for startups, providing access to resources, mentorship, and funding.

Challenges

Challenges for UK startups include uncertainties related to Brexit, which have impacted investor confidence and regulatory frameworks. The changing economic landscape requires startups to navigate new trade agreements and regulatory environments, which can be complex and uncertain.

Opportunities and Future Outlook

Despite challenges, the UK remains a leader in innovation and entrepreneurship, with significant growth potential. The UK's strategic location and strong ties with international markets provide startups with opportunities for global expansion. Additionally, the emphasis on sustainability and green technology is driving innovation in sectors such as clean energy and sustainable transportation.

Resilience and Adaptability

The UK startup ecosystem is characterized by its resilience and adaptability. Programs like Tech Nation and Innovate UK support continuous development. The emphasis on sustainability and innovation positions the UK as a key player in the global startup ecosystem. As the UK continues to adapt to post-Brexit realities, its startup ecosystem is poised for further growth and development.

overlay landing page

We found 1,186 VC firms in the United kingdom investing in BioTech on Angels Partners

Elizabeth Galbut
Investing in Media • BioTech • A.I. (& ...
 New York , San Franci..., U.S.A.
Investor Picture
Previous Investments
  • Cherry Blossom Intimates: $2000000 (Seed)
  • Torigen Pharmaceuticals: $3000000 (Series A)
  • Winky Lux: $6000000 (Series A)
  • Winky Lux: $2000000 (Seed)
  • SWAAY Media: (Seed)
  • Function of Beauty: $10000000 (Series A)
  • Function of Beauty: $1000000 (Seed)
  • Neurophos: $7000000 (Seed)
  • TaxGPT: (Pre Seed)
  • NewHomesMate (formerly Propertymate): $6000000 (Seed)
  • VitaBowl: $3000000 (Seed)
  • Zamp: $4000000 (Seed)
  • Polygraf: $2000000 (Seed)
  • lockr: $3000000 (Pre Seed)
  • OneRail: $33000000 (Series B)
  • OneRail: $9000000 (Series A)
  • Gravitics: $20000000 (Seed)
  • Biofire: $15000000 (Series A)
  • Sprocket Games: $5000000 (Seed)
  • Frenter: $210000 (Pre Seed)
  • Pryon: $12000000 (Series Unknown)
  • Buffalo Market: $20000000 (Series A)
  • Karma Biotechnologies: $3000000 (Seed)
  • Movo: $3000000 (Seed)
  • Geosite: $5000000 (Series A)

Elizabeth Galbut

New York - San Francisco - Bay Area - Los Angeles / Southern California - Boston - / New - Baltimore - Washington - Miami - City, U.S.A.

Investing In

Media • BioTech • A.I. (& Big Data) • HealthTech (& Fitness) • Developer tools • Insurance (& InsurTech) • Medical Devices (& Hospital Services) • Robotics • Healthcare (& Wellness) • Consumer

Description

Venture Capitalist | Managing Partner at SoGal Ventures *** Startup pitch decks, press inquiries, and speaking requests can be sent directly to Elizabeth@sogalventures.com *** Elizabeth is the co-founder and Managing Partner of two start-up venture capital firms, SoGal Ventures and A-Level Capital, which have collectively advised and invested in over 90 startups. Elizabeth is also Co-President of the SoGal Foundation, a non-profit on the mission to redefine the next generation of diverse founders and funders through a global chapter community education model with SoGal Chapters in over 50 cities across 6 continents. Elizabeth and her SoGal Ventures business partner Pocket Sun have been featured in numerous online, print, and video publications including: New York Times, WSJ, Fortune, Forbes, CNBC, BBC World News, Financial Times. Fast Company, Inc., Entrepreneur, SWAAY, The Straits Times, Channel News Asia, The Business Times, Sina, CrunchBase News, etc. Elizabeth has received the honor of being recognized as Entrepreneur Magazine's 100 Most Powerful Women, Forbes 30U30 in Venture Capital, JP Morgan Diversity Champion Award, TechWeek 100 Innovative Investor, and NYC 33U33. Additionally, Elizabeth is involved in innovation through her roles as: -Faculty member at the School of Visual Arts MFA Products of Design graduate program -Global keynote speaker on the topics of venture capital, cross-border business, diversity and inclusion, and venture design Prior to graduate studies, as a Strategy and Operations Consultant at Deloitte Consulting, Elizabeth focused her attention on developing long-term strategy for a variety of large healthcare clients. She contributed to business development efforts leading to over $200M of new work. Elizabeth is a proud alumnus of Georgetown University, London School of Economics, Johns Hopkins University & Maryland Institute College of Art.

Will Neale
Investing in Software (Web Marketplace Saas..) &b...
 , United Kingdom - U.K.
Investor Picture
Previous Investments
  • Stotles: $1810000 (Seed Round)
  • Sidekick: $3300000 (Pre Seed Round)
  • Ourspace: $2500000 (Pre Seed Round)
  • Payable: $6100000 (Seed Round)
  • Electric Car Scheme: $2500000 (Venture Round)
  • Hiphops.io: $650000 (Pre Seed Round)
  • Outverse: $1000000 (Pre Seed Round)
  • Klump: $780000 (Pre Seed Round)
  • Kolleno: $4000000 (Seed Round)
  • 418sec:
  • Credit Kudos: (mid stage)
  • DISPUTED.IO:
  • Hometree: (mid stage)
  • Primer:
  • proSapient:
  • SteadyPay: (mid stage)
  • Urban Jungle Insurance: (mid stage)
  • Boundless: (early stage)
  • Everpress: (mid stage)
  • flatfair: (mid stage)
  • Gameplan: (early stage)
  • Graphy: (early stage)
  • Heydoc: (mid stage)
  • King River Capital: (early stage)
  • Latitude:
  • Marshmallow: (early stage)
  • Passion Capital: (late stage)
  • StudentFinance: (early stage)
  • Uncapped:
  • Vyne: (early stage)
  • Crypto Quantique: (early stage)
  • Intruder: (mid stage)
  • Kheiron Medical: (early stage)
  • Koyo: (early stage)
  • Sano Genetics:
  • BunkerEx:
  • Countingup: (early stage)
  • LocalGlobe:
  • Seedcamp:
  • SeedLegals: (early stage)
  • WeVat: (early stage)
  • Entrepreneur First: (mid stage)
  • Hello Car: (early stage)
  • Revolut: (early stage)
  • Telleroo: (early stage)
  • Thriva: (early stage)
  • âcasă - your home run: (early stage)
  • Technology Will Save Us: (mid stage)
  • Panaseer: (early stage)
  • Property Partner: (early stage)
  • Grabyo: (early stage)
  • Fonix Mobile: (early stage)
  • Accenture: (late stage)

Will Neale

, United Kingdom - U.K.

Investing In

Software (Web Marketplace Saas..) • PropTech • BioTech • Businesses Solutions • FinTech (& Financials services) • Hardware (& Manufacturing) • Retail (& E-Commerce) • A.I. (& Big Data) • Web Security (& Privacy) • Gaming (& eSports) • Analytics • Cloud Services (& Infrastructure) • Developer tools • Food & Beverage • Insurance (& InsurTech) • Messaging • Payments • Real Estate (& Construction) • SaaS • Healthcare (& Wellness) • Investment Management • LegalTech • Mobile • Pharmaceutical (& Medicine) • Oil & Gas (& Mining) • Productivity

Description

Founder | Investor

Investor at Passion Capital


Will Neale is the Founder of Grabyo. He also is an Angel Investor. He serves as an Advisor at Disputed.io. He was also a Board Member at Property Partner and is the Founder of Fonix. Previously, he was the manager at Accenture. He holds degree of Bachelor of Arts in the field of Business Management from University of Newcastle.

Alan Chan
Investing in PropTech • BioTech • AgroT...
 San Francisco Bay Are..., U.S.A. - Canada - U.K. - Netherlands
Investor Picture
Previous Investments
  • Orig3n: $50000000

Alan Chan

San Francisco Bay Area - London - New York - Los Angeles - Hong Kong, U.S.A. - Canada - U.K. - Netherlands

Investing In

PropTech • BioTech • AgroTech • Businesses Solutions • FinTech (& Financials services) • Impact • Real Estate (& Construction) • Consumer

Description

Most Interested In

Looking for things that can change the way we act, think, live, and co-exist.


VC @vectr-ventures. Co-founded @ipiao-1. Worked @goldman-sachs. Always @duke-university Blue Devils.

Alex van Someren
Investing in IT (& TMT) • Media • BioTe...
 London, United Kingdo..., United Kingdom
Investor Picture
Previous Investments
  • FiveAI: $35000000 (Early stage VC)
  • Fluidic Analytics: $31290000 (Later stage VC)
  • Graphcore: $30000000 (Later stage VC)
  • Paragraf: $20980000 (Later stage VC)
  • XMOS: $15000000 (Later stage VC)
  • PROWLER.IO: $13000000 (Early stage VC)
  • Synthace: $7300000 (Early stage VC)
  • Slamcore: $5000000 (Early stage VC)
  • Pace: $2500000 (Seed Round)
  • Exonar Ltd: $1250000 (Seed Round)
  • SLAMcore: (Seed Round)
  • Nu Quantum:
  • Seldon: (mid stage)
  • ContactEngine: (late stage)
  • HutZero:
  • Ravelin Technology: (early stage)
  • CyLon: (early stage)
  • Lumeon Ltd: (late stage)
  • nCipher Security:
  • ANT Software Ltd: (early stage)
  • JANE™ - Cash Management Kiosks: (early stage)
  • PT Compliance, LLC: (early stage)
  • Movéo Chauffeured Services: (early stage)
  • BBD International:
  • G2V Ventures: (early stage)
  • Payteller, LLC: (early stage)
  • Cardplatforms Latin America s.a.:
  • mPOS Global sa: (early stage)

Alex van Someren

London, United Kingdom - U.K., United Kingdom

Investing In

IT (& TMT) • Media • BioTech • Hardware (& Manufacturing) • Energy • CleanTech • Web Security (& Privacy) • Material Science • Medical Devices (& Hospital Services) • Investment Management

Description

General Partner at Amadeus Capital Partners

General Partner at Amadeus Capital Partners

Ian Lane
Investing in BioTech • FinTech (& Financials...
 Cambridge, U.K. - U.S.A.
Investor Picture
Previous Investments
  • Intelex: $160000000 (Other)
  • FiveStars: $50000000 (Later stage VC)
  • SevOne, Inc.: $47100000 (Later stage VC)
  • FinanzCheck: $33000000 (Later stage VC)
  • Q4: $22000000 (Later stage VC)
  • Wave: $14600000 (Later stage VC)
  • Peloton Computer Enterprises: (Other)
  • Investment Metrics: (Other)
  • Five Star Food Service: (Other)
  • Liberty New Gate:
  • Knowlton Development:
  • Comfuture:
  • Dawson, Taylor & Company:
  • Medal (California):
  • CureFit: $113070000 (Later stage VC)
  • KhataBook: $60000000 (Later stage VC)
  • Celtra Inc.: $15000000 (Later stage VC)
  • BYBI: $7000000 (Early stage VC)
  • Discuss.IO: $5025000 (Early stage VC)
  • Mira AI: $4500000 (Early stage VC)
  • Blow Ltd.: $3500000 (Early stage VC)
  • Beauty Bakerie Cosmetics Brand: $3000000 (Seed Round)
  • Peel Works:
  • Helpling: (Later stage VC)
  • Nutrafol: (Early stage VC)
  • Limitless Technology: (Seed Round)
  • WeGift: (mid stage)
  • Percolate Inc.: (late stage)
  • Secondmind: $16000000 (Series Unknown)
  • Cambridge GaN Devices: $19000000 (Series B)
  • Unlikely AI: $20000000 (Seed)
  • Salience Labs: $12000000 (Seed)
  • CreatorIQ: $40000000 (Series D)
  • CreatorIQ: $12000000 (Series B)
  • Skupos: $31000000 (Series B)
  • Limitless: $7000000 (Series A)
  • CognitionX: $1000000 (Series Unknown)
  • Voltea: $10000000 (Series Unknown)
  • Voltea: $6000000 (Series Unknown)
  • Voltea: $4000000 (Series C)
  • Voltea: $6000000 (Series B)
  • Voltea: $5000000 (Series A)
  • MachineVantage: (Series Unknown)
  • Celtra: $15000000 (Series C)
  • Blis: $25000000 (Series B)
  • Mirriad: $15000000 (Series D)
  • Olapic: $15000000 (Series B)
  • Iluminage Beauty: $25000000 (Series Unknown)

Ian Lane

Cambridge, U.K. - U.S.A.

Investing In

BioTech • FinTech (& Financials services) • A.I. (& Big Data) • DeepTech

Description

Investment Director @ Unilever Ventures

Most Interested In

focuses on technology investments

Pierre Socha
Investing in BioTech • A.I. (& Big Data) &bu...
 Cambridge, U.K.
Investor Picture
Previous Investments
  • FiveAI: $35000000 (Early stage VC)
  • Fluidic Analytics: $31290000 (Later stage VC)
  • Graphcore: $30000000 (Later stage VC)
  • Paragraf: $20980000 (Later stage VC)
  • XMOS: $15000000 (Later stage VC)
  • PROWLER.IO: $13000000 (Early stage VC)
  • Synthace: $7300000 (Early stage VC)
  • Slamcore: $5000000 (Early stage VC)
  • Pace: $2500000 (Seed Round)
  • Exonar Ltd: $1250000 (Seed Round)
  • SLAMcore: (Seed Round)
  • CS Genetics: (late stage)
  • OriBiotech: (mid stage)
  • Ori Biotech: (mid stage)
  • Doctify: (early stage)
  • Congenica: (early stage)
  • Healx Ltd: (early stage)
  • PhoreMost Ltd: (early stage)
  • Ravelin Technology: (early stage)
  • Repositive: (early stage)
  • Improbable: (early stage)
  • OrganOx: (late stage)
  • VocalIQ:
  • Lumeon Ltd: (late stage)
  • Avesthagen: (mid stage)
  • V7: $33000000 (Series A)
  • V7: $3000000 (Pre Seed)
  • Constructive Bio: $15000000 (Seed)
  • Charco Neurotech: $10000000 (Seed)
  • Quibim: $9000000 (Seed)
  • Algolux: $18000000 (Series B)
  • Algolux: $10000000 (Series A)
  • Physna: $20000000 (Series B)
  • Physna: $7000000 (Series A)
  • Gecko Robotics: $40000000 (Series B)
  • FarmLogs: $22000000 (Series C)
  • FarmLogs: $10000000 (Series B)
  • FarmLogs: $4000000 (Series A)
  • Udacity: $110000000 (Series D)
  • Udacity: $35000000 (Series C)
  • MarkLogic: $100000000 (Series F)
  • MarkLogic: $26000000 (Series E)
  • MarkLogic: $13000000 (Series D)
  • MarkLogic: $15000000 (Series C)
  • MarkLogic: $12000000 (Series B)
  • MarkLogic: $6000000 (Series A)
  • Gild: $14000000 (Series B)
  • Gild: $8000000 (Series A)
  • Gild: $2000000 (Seed)
  • Imeem: $6000000 (Series Unknown)
  • Imeem: (Series B)
  • Imeem: $3000000 (Series A)
  • StrongView: $8000000 (Series D)
  • StrongView: $13000000 (Series B)
  • StrongView: $10000000 (Series B)
  • StrongView: $6000000 (Series A)
  • PopularMedia: $8000000 (Series C)
  • PopularMedia: $4000000 (Series B)
  • PopularMedia: (Series A)
  • LinkedIn: $53000000 (Series D)
  • LinkedIn: $5000000 (Series A)
  • SearchMe: $13000000 (Series E)
  • Funny Or Die: $15000000 (Series B)
  • Funny Or Die: (Series A)
  • adBrite: $23000000 (Series C)
  • adBrite: $8000000 (Series B)
  • adBrite: $4000000 (Series A)
  • Navigenics: $25000000 (Series Unknown)
  • Corvigo: $6000000 (Series A)
  • eMadison: $13000000 (Series A)
  • Tentarix Biotherapeutics: $35000000 (Series B)
  • Tentarix Biotherapeutics: $50000000 (Series A)
  • Enlaza Therapeutics: $61000000 (Seed)
  • ImmunOs Therapeutics: $73000000 (Series B)
  • Obviously AI: $4000000 (Series Unknown)
  • Obviously AI: $4000000 (Seed)
  • Peach Cars: $5000000 (Seed)
  • Eureka Robotics: $4000000 (Seed)
  • Agara: $4000000 (Seed)

Pierre Socha

Cambridge, U.K.

Investing In

BioTech • A.I. (& Big Data) • HealthTech (& Fitness)

Description

Early Stage Tech Investor

Most Interested In

Deep Science & Technology, Academic Spin-offs

Rob Kniaz
Investing in BioTech • Retail (& E-Commerce)...
 London, U.K.
Investor Picture
Previous Investments
  • Karakuri (Other Hardware): $8330000 (Early stage VC)
  • Hoxton Ventures: (early stage)
  • TIZARO LIMITED:
  • Fidelity Ventures:
  • Preply: $42000000 (Series C)
  • Preply: $49000000 (Series C)
  • Preply: $35000000 (Series B)
  • Preply: $10000000 (Series A)
  • MultiOmic Health: $6000000 (Seed)
  • Deblock: $12000000 (Seed)
  • Limbo: $6000000 (Seed)
  • Nomagic: $22000000 (Series A)
  • Nomagic: $9000000 (Seed)
  • Bother: (Seed)
  • Flair Impact: $2000000 (Seed)
  • Spacelift: $15000000 (Series B)
  • Spacelift: $6000000 (Series A)
  • Spacelift: $2000000 (Pre Seed)
  • FabricNano: $13000000 (Series A)
  • FabricNano: $3000000 (Seed)
  • Ochre Bio: $10000000 (Seed)
  • LiliumX: (Seed)
  • Vatic Health: (Seed)
  • SuperAwesome: $17000000 (Series Unknown)
  • SuperAwesome: $13000000 (Series C)
  • SuperAwesome: $7000000 (Series A)
  • Kheiron: $22000000 (Series A)
  • Mainframe: $30000000 (Initial Coin Offering)
  • OptimoRoute Inc.: (Seed)
  • IMMUNIO: $5000000 (Series A)
  • IMMUNIO: $3000000 (Seed)
  • Mavrx: (Series A)
  • Mavrx: (Seed)
  • Babylon: $7000000 (Seed)
  • Deliveroo: $70000000 (Series C)
  • Deliveroo: $25000000 (Series B)
  • Raptor Supplies: (Seed)
  • Campanja: $5000000 (Series A)
  • Campanja: (Series Unknown)
  • LLUSTRE: (Seed)

Rob Kniaz

London, U.K.

Investing In

BioTech • Retail (& E-Commerce) • A.I. (& Big Data) • Cloud Services (& Infrastructure) • Medical Devices (& Hospital Services) • Robotics

Description

Founding partner at Hoxton Ventures

Partner at Hoxton Ventures


Worked at @google, @intel • Investor @llustre, @campanja
Linked In Description:

Venture capital investor based in London, investing across the EU and adjacent locations. Email is the best way to reach me - info@hoxtonventures.com. No blockchain please.

Hunter Walk
Investing in Software (Web Marketplace Saas..) &b...
 San Francisco Bay Are..., U.S.A. - Global: U.S.A., Australia, Canada, Germany, U.K., Israel, France, Italy, Spain, Netherlands, Belgium, Switzerland, Denmark, Finland, Luxembourg, Malta, Iceland
Investor Picture
Previous Investments
  • Candor, Inc.: (Seed Round)
  • Habi: $5500000 (Early stage VC)
  • Alula (Other Healthcare Technology Systems): $2200000 (Seed Round)
  • Outlier (AI):
  • koodos: (Seed)
  • Resq: $39000000 (Series A)
  • Resq: $8000000 (Seed)
  • Assembly: $5000000 (Seed)
  • LIT Videobooks: $5000000 (Seed)
  • Graphite: (Seed)
  • Sanzo: $1300000 (Seed Round)
  • Sanzo: $1000000 (Seed)
  • Arthur: $3000000 (Seed)
  • Thingtesting: $300000 (Pre Seed)
  • 1 Second Everyday: (Seed)
  • Projector: $9000000 (Series A)
  • Nautilus Labs: $2000000 (Seed)
  • Radical Candor: (Seed)
  • TrueAccord: $5000000 (Series A)
  • Shyp: $2000000 (Seed)
  • Sunrise: $2000000 (Seed)
  • Wealthfront: $20000000 (Series B)
  • Schematic Labs: (Seed)
  • Path 101: $350000 (Angel)

Hunter Walk

San Francisco Bay Area - California, U.S.A. - Global: U.S.A., Australia, Canada, Germany, U.K., Israel, France, Italy, Spain, Netherlands, Belgium, Switzerland, Denmark, Finland, Luxembourg, Malta, Iceland

Investing In

Software (Web Marketplace Saas..) • BioTech • FinTech (& Financials services) • Developer tools

Description

Hunter Walk is a Co-Founder and serves as a Partner at Homebrew. He served as Board Member Shyp. He also serves as an Advisor at Resolute Ventures. Prior to Homebrew, Hunter was VP of Product at Twitter, building and leading the Product Management and User Services tea Before Twitter, he was a Partner at Battery Ventures, where he co-led the seed and early stage investing practices. He joined Google in 2003 and was responsible for AdSense product management and partnerships. Before heading to Silicon Valley for Google, he worked for DoubleClick, in venture capital and as a strategy consultant. He holds an MBA from Stanford Graduate School of Business and a BA in History from Vassar College.

Ryan Gilbert
Investing in Software (Web Marketplace Saas..) &b...
 Tel Aviv , London , S..., U.S.A. - Israel - U.K.
Investor Picture
Previous Investments
  • Vidyo: $15000000 (Series E)
  • Vidyo: $20000000 (Series E)
  • Vidyo: $17000000 (Series D)
  • Vidyo: $25000000 (Series D)
  • Vidyo: $12000000 (Series C)
  • Vidyo: $25000000 (Series C)
  • Vidyo: $15000000 (Series B)
  • AeroScout: $16000000 (Series E)
  • AeroScout: $12000000 (Series D)
  • Immediate: $16000000 (Series Unknown)
  • RiskScout: (Seed)
  • Pinnacle Realty Advisors: $5000000 (Seed)
  • Rocketplace: $9000000 (Seed)
  • Central Payments: $30000000 (Series Unknown)
  • Paperwork: $3000000 (Seed)
  • Watalook: $1000000 (Pre Seed)
  • Guideline: $200000000 (Series E)
  • Guideline: $80000000 (Series D)
  • Guideline: $35000000 (Series C)
  • Guideline: $7000000 (Series A)
  • Scrypt: (Seed)
  • Proxifile: $2000000 (Pre Seed)
  • Ease: $41000000 (Series C)
  • Ease: $19000000 (Series B)
  • Ease: $7000000 (Series A)
  • Mesh Payments: $13000000 (Series A)
  • Grabango: $14000000 (Series A)
  • Charlie Finance Co.: $9000000 (Series A)
  • Steady: $9000000 (Series A)
  • Eventbrite: $1500000 (Debt Financing)

Ryan Gilbert

Tel Aviv - London - San Francisco Bay Area, U.S.A. - Israel - U.K.

Investing In

Software (Web Marketplace Saas..) • PropTech • BioTech • Businesses Solutions • FinTech (& Financials services) • A.I. (& Big Data) • Blockchain (& Cryptos) • Web Security (& Privacy) • Insurance (& InsurTech) • Payments • Real Estate (& Construction) • Productivity

Description

Most Interested In

AI to help patients select medical providers

Not Interested In

super early stage opportunities with no technical co-founder

Camilla Dolan
Investing in BioTech • AgroTech • Messa...
 New York - London, U.K.
Investor Picture
Previous Investments
  • Eka Ventures:
  • Heist Studios: (mid stage)
  • CloudSense: (late stage)
  • Hatching Dragons: (early stage)
  • PayAsUGym: (late stage)
  • Plum Fintech: (early stage)
  • Urban Massage: (early stage)
  • Wool and the Gang: (late stage)
  • Mastered:
  • Jude: $4000000 (Seed)
  • Paired: $4000000 (Seed)
  • Fenton & Co: $1000000 (Seed)
  • Bloom & Wild: $5000000 (Series B)
  • Gousto: $1000000 (Series A)

Camilla Dolan

New York - London, U.K.

Investing In

BioTech • AgroTech • Messaging • Nanotechnology • Consumer

Description

Founding Partner at Eka Ventures

Founding Partner at Eka Ventures

Han Sikkens
Investing in Education • BioTech • FinT...
 London, U.K.
Investor Picture
Previous Investments
  • Akeneo: (late stage)
  • Immersive Labs: (mid stage)
  • IBM:
  • CloudCoverage:
  • Intel 471: (mid stage)
  • Whotype: (early stage)
  • PaySkill: (early stage)
  • Odoo: $120000000 (Private Equity)
  • Odoo: $220000000 (Private Equity)
  • Optimove: $75000000 (Secondary Market)
  • On Robot: (Series Unknown)
  • RELEX Solutions: $12000000 (Series Unknown)
  • RELEX Solutions: $22000000 (Series Unknown)
  • Darktrace: $75000000 (Series D)
  • Darktrace: $65000000 (Series C)
  • Darktrace: $23000000 (Series B)
  • Flow Traders: (Private Equity)

Han Sikkens

London, U.K.

Investing In

Education • BioTech • FinTech (& Financials services) • Hardware (& Manufacturing) • Energy • Retail (& E-Commerce) • HealthTech (& Fitness) • Medical Devices (& Hospital Services) • Healthcare (& Wellness) • Consumer

Description

Managing Director & Head of Summit Partners Europe

Most Interested In

technology sector

Piotr Kulesza
Investing in Software (Web Marketplace Saas..) &b...
 Berlin - Poland - Warsaw, Germany
Investor Picture
Previous Investments
  • Eversports: $5920000 (Early stage VC)
  • MNM Diagnostics:
  • Point Nine Capital: (mid stage)
  • RTAventures VC: (early stage)
  • Q Corporate Finance House:

Piotr Kulesza

Berlin - Poland - Warsaw, Germany

Investing In

Software (Web Marketplace Saas..) • BioTech • HealthTech (& Fitness) • Healthcare (& Wellness) • Consumer

Description

Founder and General Partner at RTA.vc

Most Interested In

I'm interested in early stage VC funds (including solo GPs). I invested among others in these funds: Point Nine Capital, Adjacent, RABA Partnership, Market One Capital, Amino Collective.



Piotr Kulesza is a Co-Founder & Managing Partner at RTAventures. He is an Angel Investor. He served as Advisor of Infermedica. He also serves as an Advisor at Point Nine Capital.He is engaged in the investments of Poland since 1998. In 2009-2011 worked in the venture fund managed by Enterprise Investors, where he made an investment in the Polish Stem Cell Bank, currently the third-largest bank umbilical cord blood Europe - www.famicord .eu. During the years 2002-2009 has advised on several projects, purchase or sale of companies in Poland and Central and Eastern Europe leading his own investment boutique.

Join the community

Connect with investors & startup founders

Comprehensive Guides to Finding Startup Investorsin the United kingdom

By clicking on "Create Account" you accept our terms of service

Already have an account?
Login
Mike testimonial

Michael Colin - Founder of The MVMT



"We met the perfect Angel Investor within the Angels Partners Investors' Community. We received a $250,000 check after 2 months of discussions with investors on the platform."

Taylor Testimonial

Taylor Matter - Founder & CEO, Hurdle Apparel



"Raising Capital for a consumer venture can be rather difficult and Angels Partners helped connect the dots and helped us meet 2 investors who investors $200,000 in our brand."

founder clement

Clément Perrot - Co-Founder & CEO of Prynt



"Met really good investors who invested in Prynt, that I wouldn’t have met otherwise. Angels Partners helped us close our round quicker and with the right people."


Create An Account
Copyright © 2024 - All trademarks and copyrights belong to their respective owners.
proof notifcation
32 New Startups Started their fundraising over the last 7 days